Intranasal treatment with the mitochondria-targeted slow hydrogen sulfide releasing donor AP39 prevents inflammation-induced airway hyperreactivity in mice | AVESİS

Hacettepe University Research Information System

Intranasal treatment with the mitochondria-targeted slow hydrogen sulfide releasing donor AP39 prevents inflammation-induced airway hyperreactivity in mice

Copy For Citation

Karaman-Kutluay Y., Kaya-Yasar Y., Bozkurt T. E., Önder S. Ç., Sahin-Erdemli I.

European-Respiratory-Society (ERS) International Congress, Madrid, Spain, 28 September - 02 October 2019, vol.54

Publication Type: Conference Paper / Summary Text
Volume: 54
Doi Number: 10.1183/13993003.congress-2019.pa3879
City: Madrid
Country: Spain
Hacettepe University Affiliated: Yes